AMRA Headlines as Lead Partner @ The 3rd Annual Obesity and Weight Loss Drug Development Summit!
📅 SAVE THE DATE: July 14th – 16th, 2025 | Boston, MA LINKÖPING, Sweden, July 3, 2025 – We are absolutely thrilled to join…
Read MoreMedical Research
📅 SAVE THE DATE: July 14th – 16th, 2025 | Boston, MA LINKÖPING, Sweden, July 3, 2025 – We are absolutely thrilled to join…
Read MoreMedical Research
LINKÖPING, Sweden, June 19, 2025 AMRA Medical was thrilled to attend the 2025 International Research Congress, hosted by the FSHD Society! The conference,…
Read MoreMedical Research
LINKÖPING, Sweden, June 17, 2025 – A newly-published study, led by Mattias Ekstedt’s ectopic fat study group at the Department of Health, Medicine…
Read MoreMedical Device
AMRA Medical releases the gold-standard MRI-based fat and muscle composition analysis service for use in clinics across Sweden and Germany
Read MoreMedical Research
A recent post-hoc analysis of Lilly’s SURPASS-3 trial unravels the impact of tirzepatide treatment on muscle volume and fat infiltration in individuals with Type 2 Diabetes
Read MoreMedical Research
Recent AMRA research examines whether the use of MRI-based biomarkers as surrogate endpoints in DMD clinical trials is feasible, allowing for more informative descriptions of disease severity and progression in DMD
Read More